1086381-28-3

Usage

Uses

Used in Pharmaceutical Industry:
4-Bromo-2-(cyclopropyl)pyridine is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs with improved therapeutic properties. The presence of the bromine and cyclopropyl groups allows for further chemical modifications, enhancing the compound's potential in medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical sector, 4-Bromo-2-(cyclopropyl)pyridine serves as an essential intermediate for the production of agrochemicals, including pesticides and herbicides. Its unique structural features enable the creation of compounds with targeted effects on pests and weeds, contributing to more effective and environmentally friendly agricultural solutions.
Used in Organic Chemistry Research:
4-Bromo-2-(cyclopropyl)pyridine is utilized as a building block in organic chemistry research for the creation of complex molecules with novel properties. Its structural attributes make it a valuable starting material for the synthesis of a wide range of chemical compounds, driving innovation in the field of organic chemistry and the discovery of new applications.

Upstream product

• 19524-06-2 4-bromopyridine hydrochloride 
• 23719-80-4 cyclopropylmagnesium bromide 
• 58530-53-3 2,4-dibromopyridine 

Downstream Products

• 1227162-93-7 1-(3-bromophenyl)-1-(2-cyclopropylpyridin-4-yl)-4-fluoro-1H-isoindol-3-amine 

Relevant academic research and scientific papers

SYNTHESIS OF HETEROCYCLIC COMPOUNDS

Provided herein are intermediates and processes useful for facile synthesis of compounds of Formula 2: wherein R1 is C(O)R2; R2 is alkyl optionally substituted with 1-5 halogens; G is phenyl or a 5-6 membered heteroaryl op

QUINOLINE-BASED KINASE INHIBITORS

The present disclosure is generally directed to compounds of formula (I) which can inhibit AAKI (adaptor associated kinase 1), compositions comprising such compounds, and methods for inhibiting AAKI.

5H-PYRROLO[3,4-￡>]PYRAZIN-7-AMINE DERIVATIVES INHIBITORS OF BETA-SECRETASE

The present invention relates to novel compounds of formula (I) and their pharmaceutical compositions. In addition, the present invention relates to therapeutic methods for the treatment and/or prevention of Aβ-related pathologies such as Downs syndrome, β- amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI ("mild cognitive impairment"), Alzheimer Disease, memory loss, attention deficit symptoms associated with Alzheimer disease, neurodegeneration associated with diseases such as Alzheimer disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration.

NEW COMPOUNDS 578

The present invention relates to novel compounds of formula (I) and their pharmaceutical compositions. In addition, the present invention relates to therapeutic methods for the treatment and/or prevention of Aβ-related pathologies such as Downs syndrome, β-amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI (“mild cognitive impairment”), Alzheimer Disease, memory loss, attention deficit symptoms associated with Alzheimer disease, neurodegeneration associated with diseases such as Alzheimer disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration.